右美托咪定在重症监护病房谵妄治疗中的应用价值

Abstract
Figure/Table
References (15)
Related Citation (15)

Download: PDF (0 KB) HTML (31 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To explore the value of Dexmedetomidine in the treatment of sputum in intensive care unit(ICU).Methods Fifty patients with ICU delirium who were admitted to our hospital from June 2016 to July 2017 were selected as study subjects.They were assigned to the observation group and the control group according to the random number table method, with 25 cases in each group.The observation group was treated with Dexmedetomidine, and the control group was given intravenous Haloperidol.The ICU treatment time, total hospital stay, ideal sedation time, Richmond agitation-sedation scale (RASS) score, and clinical adverse reactions were compared between the two groups.Results The ICU treatment time and total hospitalization time of the observation group were shorter than those of the control group, and the differences were statistically significant (P＜0.05).The ideal sedation time of the observation group was shorter than that of the control group, and RASS score of the observation group was lower than that of the control group, and the differences were statistically significant (P＜0.05).There were no serious side effects in either group.The incidence of hypotension, bradycardia or sinus arrest were lower in the observation group than those in the control group, and the differences were statistically significant (P＜0.05).Conclusion Dexmedetomidine in the treatment of patients with ICU can reduce the occurrence of sputum and cure ICU patients as soon as possible, which can shorten the hospitalization time of ICU sputum patients and reduce medical expenses, and has high clinical value.

Key words： Dexmedetomidine Intensive care unit Delirium Application value

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	SONG Jia-cai
	CAI Long
	TANG Yi

Cite this article:

SONG Jia-cai,CAI Long,TANG Yi. Application value of Dexmedetomidine in the treatment of intensive care unit delirium[J]. 中国当代医药, 2020, 27(3): 88-90.

URL:

http://dangdaiyiyao.com/EN/ OR http://dangdaiyiyao.com/EN/Y2020/V27/I3/88

[1]	孙跃辉.右美托咪定在ICU 高血压脑出血术后患者中的临床应用效果[J].当代临床医刊，2019，32（2）：159，170.
[2]	方秋英，杨小春.右美托咪定对门诊面部局部麻醉手术超前镇静的影响[J].当代医学，2019，25（10）：144-146.
[3]	朱丽萍.浅析集束化护理预防心外术后患者ICU 谵妄的应用价值[J].医学理论与实践，2019，32（6）：898-900.
[4]	黄玉敏.右美托咪定联合个性化约束在ICU 谵妄患者中的应用及护理[J].当代护士（中旬刊），2016，（11）：85-86.
[5]	张妍，苏晓蕾，赵睿，等.右美托咪定或咪达唑仑复合舒芬太尼在有创机械通气患者镇静中的效果对比[J].中国当代医药，2019，26（5）：181-183，202.
[6]	陈高斯.咪达唑仑联合右美托咪定对ICU 机械通气患者的镇静效果研究[J].继续医学教育，2019，33（1）：128-130.
[7]	李岩，赵渊博，于湘友.老年肥胖患者机械通气治疗给予丙泊酚联合右美托咪定镇静效果及安全性分析[J].中国临床医生杂志，2019，47（1）：33-35.
[8]	付国东，徐玲芬，钮富荣，等.护士主导的ICU 谵妄预防实践方案的初步构建[J].护理学杂志，2018，33（24）：87-91.
[9]	姜晓东，于昕冉，于健.ICU 围术期机械通气患者应用右美托咪定镇静效果观察[J].中国现代药物应用，2018，12（20）：80-82.
[10]	向志国.不同浓度右美托咪定对机械通气患者镇静疗效的比较研究[J].中国继续医学教育，2018，10（25）：62-64.
[11]	侯祝栓.右美托咪定对ICU 机械通气患者的镇静效果观察[J].河南医学研究，2018，27（15）：2765-2766.
[12]	葛雅秋，沈方，庄莹莹.预防患者ICU 谵妄中综合护理的临床应用分析[J].实用临床护理学电子杂志，2018，3（35）：80，82.
[13]	王卫军.右美托咪定和咪达唑仑用于ICU 术后机械通气的镇静效果及安全性分析[J].现代医药卫生，2018，34（11）：1701-1703.
[14]	邢乃姣，王梅，孙晓娜，等.右美托咪啶联合奥氮平在心脏术后ICU 谵妄的疗效评价[J].精神医学杂志，2018，31（3）：214-217.
[15]	王梦婕.右美托咪定镇静与ICU 谵妄的临床研究[D].长沙：湖南师范大学，2018.